Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia--a clinical observation in geriatric patients

Gerontology
Hans Jürgen HeppnerC C Sieber

Abstract

Community-acquired pneumonia is a common disease of the elderly and involves a high mortality risk. Demographic developments are creating new challenges for acute medical treatment strategies in geriatric patients with their underlying multimorbidity. In addition to the diagnostic parameters recorded on hospital admission, such as white cell count and C-reactive protein, procalcitonin, more than the risk scores CRB- and CURB-65 evaluated to date, appears to be a promising parameter for assessing the severity of pneumonia in elderly patients to allow early detection of severe courses and initiation of suitable treatment. The decisive factor is the dynamic course of the procalcitonin values over 3 consecutive days, as demonstrated in this case series.

Citations

Jul 9, 2013·Critical Care Clinics·Hans Jürgen HeppnerSingler Katrin
Sep 4, 2015·Zeitschrift für Gerontologie und Geriatrie·Thomas BertschHans Jürgen Heppner
May 20, 2015·Zeitschrift für Gerontologie und Geriatrie·M HortmannM Christ
Jul 15, 2016·Deutsches Ärzteblatt International·Jörg Bätzing-FeigenbaumWinfried V Kern
Jan 11, 2022·Wiener medizinische Wochenschrift·Hans Jürgen Heppner, Hag Haitham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.